A homology model of the M 1 muscarinic acetylcholine receptor, based on the X-ray structure of bovine rhodopsin, has been used to interpret the results of scanning and point mutagenesis studies on the receptor's transmembrane (TM) domain. Potential intramolecular interactions that are important for the stability of the protein fold have been identified. The residues contributing to the binding site for the antagonist, N-methyl scopolamine, and the agonist, acetylcholine, have been mapped. The positively charged headgroups of these ligands probably bind in a charge-stabilized aromatic cage formed by amino acid side chains in TM helices TM3, TM6 and TM7, while residues in TM4 may participate as part of a peripheral docking site. Closure of the cage around the headgroup of acetylcholine may be part of the mechanism for transducing binding energy into receptor activation, probably by disrupting a set of Van der Waals interactions between residues lying beneath the binding site that help to constrain the receptor to the inactive state, in the absence of agonist. This may trigger the reorganization of a hydrogen-bonding network between highly conserved residues in the core of the receptor, whose integrity is crucial for achievement of the activated state.
Introduction
The seven-transmembrane (TM) G-protein-coupled receptors are the largest superfamily of TM signalling molecules in the mammalian genome. The muscarinic acetylcholine (ACh) receptors (mAChRs) were among the earliest members of this family to be defined pharmacologically [1] . They share essential sequence motifs with rhodopsin, which is the only seven-TM receptor for which direct three-dimensional structural information has been obtained [2] [3] [4] [5] . Mutagenesis, protein labelling and spectroscopic studies suggest that similar mechanisms of activation operate in rhodopsin, several of the cationic amine receptors, including mAChRs, and neuropeptide receptors [6] .
The five genetically distinct mAChR subtypes fall into two main groups. The M 1 , M 3 and M 5 mAChRs couple preferentially to G-proteins of the G q /G 11 class, which leads to phosphoinositide breakdown. In contrast, M 2 and M 4 mAChRs couple primarily to G-proteins of the G i and G o classes, typically leading to adenylate cyclase inhibition and the activation of inward-rectifier potassium conductances. Among a plethora of other possible responses, in a suitable cellular context, all of the mAChR subtypes can activate non-receptor tyrosine kinases, transactivate the epidermal growth factor receptor and activate extracellular signalrelated protein kinase cascades [7] .
Use of scanning mutagenesis to probe the functions of amino acids in receptor sequences
Scanning mutagenesis techniques allow the function of each amino acid side chain within a particular protein sequence to be assessed, relative to its neighbours, and provide information that can be used to interrogate or refine a homology model of the protein, in the absence of direct structural information. Alanine scanning mutagenesis (alanine itself is replaced by glycine, although this is not an ideal substitution) deletes the side chain of each residue beyond the β-carbon atom. In principle, this leaves a small hole in the three-dimensional structure of the receptor. In the M 1 mAChR, when expressed in COS-7 cells, this perturbation is surprisingly well tolerated. This technique pinpoints important residues, whose function can be examined by introducing a series of point mutations, or by techniques such as combinatorial histidine-or cysteine-substitution mutagenesis [8] [9] [10] .
The simplest mechanistic model that is adequate to interpret receptor mutagenesis studies is the extended ternary complex model of agonist-receptor-G-protein interaction, which was first proposed to account for the phenomenon of agonist-independent signalling induced by particular mutations [11] . The primary assumption is that the receptor exists in one of two states -active or inactive -that are in an equilibrium that is governed by an equilibrium constant K (assumed to be 1 for the wild-type receptor). Ligands that bind to the receptor may favour either the activated state or the inactive state, or have neutral properties. The activated state of the receptor is postulated to bind the G-protein, and catalyse GDP-GTP exchange, which leads to downstream signalling.
An implication of this mechanism is that the receptor will display basal signalling activity. This is governed by the magnitude of K, the avidity of the G-protein for the activated state of the receptor, and the concentration of the receptor relative to the G-protein. For a particular agonist, such as ACh, a measure of its signalling efficacy at a particular mutant receptor can be taken as the effective affinity of the G-protein for the activated state of the receptor, weighted by the fraction of receptors that are in the activated state, when the receptors are fully occupied by the agonist. This can be estimated by a combination of measurements of agonist affinity, signalling potency, receptor expression level and basal signalling activity.
Homology model of the M 1 muscarinic receptor
Scanning mutagenesis studies are synergistic with homology modelling, and they provide data that can be used to validate and refine the model. We have built a model of the M 1 mAChR by threading the sequence of the receptor on to the rhodopsin backbone, followed by energy minimization [12, 13] . and with a 129-amino-acid deletion in the third intracellular loop) on to the backbone structure of rhodopsin, followed by energy minimization, as described [12] . supplemented, on the occasion of their first appearance, by a designation according to the scheme of Ballesteros and Weinstein [14] , in which the position of the most conserved amino acid in TM helix N is represented by N.50, and other amino acids in the same helix are numbered accordingly.
In the model, TM helices TM1, TM2, TM3, TM5, TM6 and TM7 are arranged in an approximate ellipse that is buttressed by TM4, which crosses the outer surfaces of TM3 and TM2. An eighth, cytoplasmic, helix projects at right angles from the C-terminus of TM7, and lies along the surface of the cell membrane, where it is presumed to be anchored by a palmitoylated cysteine residue. As in rhodopsin, kinks are modelled in the TM helices, particularly in TM4, which is bent near Pro 157 (4.59), and TM6 and TM7, which sharply change direction near the conserved Pro 380 (6.50) and Pro 415 (7.50). The outer sections of the TM helices have a left-to-right tilt, which defines a distorted, pear-shaped barrel, floored by the upper surface of the highly-tilted TM3, and the inwardpointing elbow in TM7. The bulb of this cavity contains the binding site, and it is strongly constricted at its base where the distorted proline kink of TM7 projects inwards towards TM2. The proline residue is part of the NSXXNPXXY motif, which is a signature of the seven-TM A receptors. The second extracellular (e 2 ) loop is modelled as a twisted β-hairpin pinned to the top of TM3 by the very highlyconserved disulphide bond. The e 2 loop helps to form the roof of the binding site. In rhodopsin, the N-terminal domain forms a second pair of β-strands. We have no way of knowing whether this is present in the M 1 mAChR, and it is omitted from the model. In our model, there is a 129-amino-acid deletion in the third intracellular (i 3 ) loop, based on a deletion mutant that retains unchanged ligand binding activity and shows good signalling activity [15] . As with the rhodopsin structure, the intracellular loops are modelled as a canopy that spreads out from the TM core.
Scanning mutagenesis of the TM domain of the M 1 muscarinic receptor
We have used scanning mutagenesis to survey the roles of amino acids in TM2, TM3, TM4, TM5, TM6 and TM7 of the M 1 mAChR [10, 12, [15] [16] [17] [18] [19] [20] . Our interpretation of the results is outlined below. (3.51) are the most important of the residues whose mutational phenotypes suggest a pure structural stabilization role. The crystal structure of rhodopsin shows that the counterpart of Trp 150 , one of the most conserved residues in the entire rhodopsinlike seven-TM receptor family, participates in a network of hydrogen bonds that links TM4 to TM2 and TM3. Similar linkages may be present in the M 1 mAChR.
Intramolecular interactions that stabilize the receptor structure
In rhodopsin, a vicinal salt bridge exists between the glutamate and arginine residues of the Asp/Glu3.49-Arg3.50-Tyr3.51 triad. Mutational disruption of this link causes partial activation of rhodopsin, with similar effects reported in several monoamine receptors [21] [22] [23] [24] , which has prompted suggestions that the salt bridge may be a common feature in these receptors. However, this behaviour is not replicated in the M 1 mAChR [15] . We propose that Asp 122 does interact not with Arg 123 , but with a concentration of positive charges in the second intracellular loop near TM4, while Tyr 124 forms a stacking interaction with a substantially conserved proline residue in the second intracellular loop, as found in rhodopsin.
Binding site for ACh and N-methyl scopolamine (NMS)
Alanine substitution mutation has allowed us to identify most of the residues in the TM region that anchor the high-affinity antagonist NMS and the natural agonist ACh in the groundstate binding site of the M 1 mAChR.
The active S-(-)-enantiomer of NMS can be docked into the M 1 mAChR model along a trajectory that is equivalent to that defined by the retinal chromophore in rhodopsin, after allowing small, outward rigid-body movements of TM6 and TM7, to relieve unfavourable contacts [12, 13] (Figure 2A ), a group that includes seven of the nine ligandanchor residues whose alanine substitution mutation caused >30-fold reduction in NMS affinity.
When thus positioned, the head group of NMS is located within a charge-stabilized aromatic cage, as originally suggested by Hibert et al. [25] , on the basis of modelling studies. The preponderance of aromatic residues is consistent with the composition of the binding sites of the nicotinic receptor [26] and acetylcholinesterase [27] , and in accordance with the theoretical studies of Ma and Dougherty [28] . Interestingly, the phenyl ring of NMS, whose position resembles that of the β-ionone ring of retinal, is predicted to be close to Asn 110 (3.37), Val 113 (3.40) and Phe 374 (6.44), whose mutations caused approx. 10-fold reductions in NMS affinity. The phenyl ring of atropine analogues, and the ionone ring of retinal may reinforce the mutual interactions of TM3, TM5 and TM6, which explains the inverse agonist activity of these ligands.
The scanning mutagenesis studies suggest that ACh is bound in a similar manner to NMS, but that its side chain does not extend as deeply into the TM region.
A transferred nuclear Overhauser effect NMR study of the ACh analogue S-(+)-acetyl-β-methyl choline when bound to the M 2 mAChR has suggested that the conformer, which is bound in the ground state of the muscarinic binding site, is gauche, with an NCCO torsion of angle of 60
• [29] . Assuming that this applies to other muscarinic subtypes, we have docked the gauche conformer of ACh into the model of the M 1 mAChR (Figure 2B ), placing the ester function of ACh so that its carbonyl oxygen is anchored by hydrogen bonding to the hydroxy group of Tyr 381 , and the ester oxygen to the hydroxy group of Tyr 106 . Analysis of the properties of the Tyr → Phe relative to the Tyr → Ala mutants suggested that the tyrosine hydroxy groups are important in anchoring ACh in the binding site, but that the aromatic rings are dominant for transducing the binding energy of ACh into receptor activation [19] (3.26) , which is located at the N-terminal end of TM3. This residue has been proposed to act as a primary contact residue before ligands enter the central binding site [30] . We have postulated that this more superficially located cluster of amino acids may participate in an obligatory ligand docking step [12] , while Pro 159 provides an indirect conformational switch to reposition Trp 157 , which may then contribute to high-affinity binding and receptor activation [31] .
Intramolecular contacts that selectively stabilize the ground state
The two-state model of receptor activation predicts that alanine substitution of side-chains whose intramolecular contacts stabilize the ground state, but not the activated state, of the receptor should decrease receptor stability, increase agonist affinity and induce agonist-independent basal signalling activity. This phenotype is most clearly seen in the case of Leu 116 (3.43) [20] . In the M 5 mAChR, mutations of Phe 6.44 and Ile 6.40 (corresponding to Phe 374 and Ile 370 in the M 1 mAChR) have also been reported to induce constitutive activity [32] . These residues may have a general function in coupling TM helix movements with receptor activation [33] . The constituents of the conserved NSXXNPXXY sequence in TM7 share some of these characteristics, yielding an increase in ACh affinity, coupled with decreased expression, on mutation to alanine. The engineering of a Zn 2+ -binding site with micromolar affinity by multiple histidine-substitution mutagenesis suggested, in the context of an earlier, low-resolution model of the M 1 mAChR, that the side chains of Leu 116 , Phe 374 and Asn 414 might be close enough to interact with one another by Van der Waals contact in the ground state of the M 1 mAChR [9] . In the rhodopsin homology model for M 1 mAChR, a contact between Leu 116 and Phe 374 is confirmed, but it seems more likely that the underlying residue, Ile 370 , extends this set of contacts to Asn 414 , a suggestion that is rendered plausible by the X-ray structure of rhodopsin, in which the homologous Met 257 (6.40) may be close enough to contact the NPXXY domain. In TM2, the alanine mutants of Asn 61 (2.40) and Leu 64 (2.43) share a similar phenotype. The model suggests that these may interact with Tyr 418 (7.53), which in addition forms a stacking interaction with a conserved Phe in the H8 helix. The most important of these putative interactions are illustrated in Figure 3 .
It is proposed that these contacts contribute to an extended hydrophobic latch structure [34] , which helps to stabilize the ground-state structure of the receptor. In general, mutagenic disruption of these contacts should favour the activated conformation of the receptor. A particular effect of this would be to increase the mobilities of TM6 and TM7 relative to that of TM3.
Intramolecular contacts that are critical for receptor activation
In the model of the ground state of the M 1 mAChR, as in rhodopsin, Asp 71 (2.50) is the centrepiece of a hydrogenbonding network linking TM2 to TM1 via Asn 43 (1.50) and TM7 via the backbone carbonyl at Ser 411 (7.46) in the NSXXNPXXY motif (Figure 3 ). In rhodopsin, there is also a water-mediated hydrogen bond between Asp 2.50 and 7.49, as well as further water-mediated contacts between positions 6.40 and 7.49 [35] . The mutation of Asn 43 , like Asn 414 , reduces the expression level of the M 1 mAChR (by 90%) and induces a 10-fold increase in ACh affinity, but causes a 10-fold decrease in signalling efficacy.
The existence of these ground-state contacts would help to explain why mutations of Asn 43 , Asp 71 and Asn 414 cause such large decreases in receptor expression levels. However, these residues must have a dual role because they are also critical for receptor activation. It is likely that the NSXXNPXXY motif plays a central role in the conformational switch, contributing a rearranged set of contacts that stabilize the activated state of the receptor. These may include Tyr 418 and Asn 43 . The re-orientation of Tyr 418 could transmit the conformational change onward to the H8 helix. The recent study by Okada et al. [35] suggests that, in rhodopsin, rearrangement of the water-mediated hydrogen-bonding network connecting TM2, TM3, TM6 and TM7 must be a key feature of activation.
In the M 1 mAChR model, as in rhodopsin, the very highly conserved Arg 123 (3.50), which is important for G-protein binding and critical for signalling, forms a charge-stabilized hydrogen bond with Glu 360 (6.30), a residue that is conserved in most monoamine receptors, as well as the rhodopsins. Mutation of this acidic residue, at the cytoplasmic boundary of TM6, causes constitutive activation of the M 1 mAChR [36] and the serotonin 5HT2A receptor [24] , consistent with the existence of a constraining bond. The absence of a large effect of mutating Arg 123 on receptor expression levels [17] suggests that this bond does not make a net contribution to receptor stability.
Transduction of ACh binding energy into receptor activation
Compared with the bulky scopine headgroup of NMS, the tetramethylammonium headgroup of ACh occupies a smaller volume within the binding cleft (Figures 2A and 2B) . Because of the importance of the aromatic moieties of the tyrosine residues for signal transduction, we have suggested that the closure of the charge-stabilized hydrophobic cage, thereby eliminating the cavity around the ACh headgroup, may provide part of the binding energy to drive receptor activation [12] . This would explain why tetramethylammonium ions can activate mAChRs, while ethyl substitutions on the quaternary nitrogen of ACh strongly and progressively reduce signalling efficacy, and, more generally, why muscarinic agonists of high efficacy have compact, positively-charged headgroups [37] .
Analysis of structure-activity data shows the conformation of bound ACh to be trans (anticlinal) in the activated state of the receptor, with an NCCO angle of approx. 132
• [38] . This suggests that the transition of ACh from a gauche conformation to an extended conformer may be part of the activation process. This might lead to a change in the hydrogen-bonding pattern of the agonist. It has not proved possible to fit the trans conformer of ACh into the groundstate model of the ACh binding site [12] .
Tightening of the aromatic cage around the headgroup of ACh should precipitate movements of TM6 and TM7, relative to TM3. It is interesting that the mutation data suggest that several of the residues which participate in ACh binding, particularly Asp 105 , Tyr 381 , Asn 382 and Tyr 408 , also make intramolecular structural contacts. The rearrangement of these might help to disrupt the deeper intramolecular contacts that lie beneath the binding site, including the hydrophobic latch structure, and the ground-state hydrogenbond networks, thus triggering their replacement by a new set of contacts which favour the activated state. In all of the mAChR subtypes, mutational disruption of the contacts made by the outer segment of TM6 can trigger constitutive activation [39] . In the β 2 , NK1 and complement factor 5a (C5a) receptors, as well as in rhodopsin, a movement of the outer segment of TM7 relative to TM3 also appears to be important in activation (reviewed in [13] ).
The nature of the agonist-induced conformational change is amenable to a mutagenesis and protein engineering approach, as recently shown, for example for the M 3 mAChR, in an elegant study by Ward et al. [40] , in which disulphidebond trapping was used to demonstrate a movement of the cytoplasmic end of TM6 towards TM5, on agonist binding. In the future, our ability to overexpress M 1 mAChRs [41] , coupled with the availability of constitutively active mutants, may allow a direct crystallographic approach to the determination of the structure of both the ground and the activated states of these receptors and their complexes. 
